IRONDisc Medicine, Inc.

HealthcareUSD
$82.64

The financials

Disc Medicine, Inc. by the numbers

Disc Medicine, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$65M−$61Mn/a
Net income−$60M−$55Mn/a
Diluted EPS−$1.54−$1.58n/a

Biotechnology

Ranks #109 of 145 by Smart Score

Compare peers
KLRA-3.3%
Kailera Therapeutics, Inc.
CLDX+0.92%
Celldex Therapeutics, Inc.
TARS-4.1%
Tarsus Pharmaceuticals, Inc.
TRVI+2.7%
Trevi Therapeutics, Inc.
RARE+0.48%
Ultragenyx Pharmaceutical Inc.
VERA+2.5%
Vera Therapeutics, Inc.